Safety and Efficacy Study of HO/03/03 10-40 Micro Grams to Treat Hard to Heal Wounds

NCT01772303 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Hard to Heal Wounds

Interventions

DRUG: HO/03/03 10-40 µg

Sponsor

HealOr